Why the study?
Compliance with VTE guidelines varies after THA and TKA, and the association between non-compliance with AOA VTE prophylaxis guidelines and VTE risk was uncertain.
Does non-compliance with AOA VTE prophylaxis guidelines reduce symptomatic 90-day VTE in adults undergoing primary TKA/THA?
Does non-compliance with AOA VTE prophylaxis guidelines reduce symptomatic 90-day VTE in adults undergoing primary TKA/THA?
Non-compliance with AOA VTE prophylaxis guidelines was counterintuitively associated with a lower risk of symptomatic 90-day VTE after joint arthroplasty, suggesting a need to review the guidelines.
Guideline non-compliance was associated with lower VTE risk after TKA/THA; hypothesis-generating and should not yet change practice.
BackgroundPreventing avoidable venous-thrombo-embolism (VTE) is a priority to improve patient and service outcomes after total hip and total knee arthroplasty (THA, TKA), but compliance with relevant clinical guidelines varies. This study aims to determine the degree to which prophylaxis was compliant with Australian Orthopaedic Association (AOA) VTE prophylaxis guidelines and whether non-compliance is associated with increased risk of VTE.Methods A prospective multi-centre cohort study of adults with osteoarthritis undergoing primary TKA/THA was completed at 19 high-volume public and private hospitals. Data were collected prior to surgery and for one-year post-surgery. Logistic regression was undertaken to explore associations between non-compliance with AOA VTE prophylaxis guidelines and symptomatic 90-day VTE outcomes. ResultsData were analysed for 1838 participants from 19 sites. The rate of non-compliance with all clinical guideline recommendations was 20.1% (N = 369), with 14.1% (N = 259) non-compliance for risk-stratified prophylaxis, 35.8% (N = 658) for duration, and 67.8% (N = 1246) for other general recommendations. Symptomatic VTE was experienced up to 90-days post-surgery by 48 people (2.6%). Overall guideline non-compliance (AOR = 0.1, 95%CI = 0.0 to 0.4, p = 0.006) was associated with a lower risk of symptomatic 90-day VTE. Results were consistent when people with high bleeding risk were excluded (AOR = 0.13, 95% CI = 0.02 to 0.49, p = 0.005).ConclusionsNon-compliance with the AOA VTE prophylaxis guidelines was associated with fewer VTEs within 90 days of arthroplasty. This counterintuitive finding is concerning and necessitates a rigorous review of the AOA VTE prevention clinical guideline.
No takes yet. Share an insight, caveat, or question.
Badge et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: